Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2023
Source ID
10.1016/j.biomaterials.2023.122062

Entities

People

  • Aaron P Esser-Kahn
  • Adam M. Weiss
  • Elizabeth J. Mulder
  • Jingjing Shen
  • Saikat Manna
  • Sampa Maiti
  • Wenjun Du

Organizations

  • Defense Threat Reduction Agency
  • National Institutes of Health
  • National Science Foundation
  • University of Chicago